Abstract:The antiviral endoribonuclease, RNase L, is activated by the mammalian innate immune response to destroy host and viral RNA to ultimately reduce viral gene expression. Herein, we show that RNase L and RNase L-mediated mRNA decay are primarily localized to the cytoplasm. Consequently, RNA-binding proteins (RBPs) translocate from the cytoplasm to the nucleus upon RNase L activation due to the presence of intact nuclear RNA. The re-localization of RBPs to the nucleus coincides with global alterations to RNA processing in the nucleus. While affecting many host mRNAs, these alterations are pronounced in mRNAs encoding type I and type III interferons and correlate with their retention in the nucleus and reduction in interferon protein production. Similar RNA processing defects also occur during infection with either dengue virus or SARS-CoV-2 when RNase L is activated. These findings reveal that the distribution of RBPs between the nucleus and cytosol is dictated by the availability of RNA in each compartment. Thus, viral infections that trigger RNase L-mediated cytoplasmic RNA in the cytoplasm also alter RNA processing in the nucleus, resulting in an ingenious multi-step immune block to protein biogenesis. Ribonuclease L (RNase L) initiates rapid and widespread degradation of cellular mRNAs in response to double-stranded RNA or viral infection. How the mass degradation of mRNAs affects cellular functions is unknown. Herein, we show that RNase L-mediated mRNA decay is predominately localized to the cytoplasm. Consequently, RNA-binding proteins re-localize from the cytoplasm to the nucleus upon RNase L activation. Coinciding with the influx of RNA-binding proteins into the nucleus, we also observe perturbation of nuclear processing of mRNAs, and these processing defects down-regulate key antiviral cytokines, such as type I interferons. Importantly, we observe these processes occurring during dengue virus and SARS-CoV-2 infection, revealing previously unknown aspects of antiviral gene regulation during pathogenic viral infections. Combined, these findings uncover novel mechanisms by which RNase L regulates host gene expression and expand the potential means by which RNase L blocks protein synthesis.

Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence

Regulatory RNA-binding proteins in senescence.

Nucleolar stress caused by arginine-rich peptides triggers a ribosomopathy and accelerates aging in mice

Rdrp-Synthesized Antisense Ribosomal Sirnas Silence Pre-Rrna Via the Nuclear Rnai Pathway

RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus

CRISPR screening uncovers nucleolar RPL22 as a heterochromatin destabilizer and senescence driver

Mtorc1-Rps15 Axis Contributes to the Mechanisms Underlying Global Translation Reduction During Senescence of Mouse Embryonic Fibroblasts

RNA-based logic for selective protein expression in senescent cells

Tuning of ribosome levels mediated by RNase I and hibernating ribosomes

A New Layer of Rrna Regulation by Small Interference RNAs and the Nuclear RNAi Pathway

Ribosome clearance during RNA interference

Ribosomal RNA transcription governs splicing through ribosomal protein RPL22

Identification of the Lncrna, AK156230, As a Novel Regulator of Cellular Senescence in Mouse Embryonic Fibroblasts.

Regulatory RNAs in immunosenescence

Retinoic acid inducible gene-I slows down cellular senescence through negatively regulating the integrin β3/p38 MAPK pathway

Antisense Ribosomal Sirnas Inhibit RNA Polymerase I-directed Transcription in C. Elegans.

Expression of the Leo1-Like Domain of Replicative Senescence Down-Regulated Leo1-Like (rdl) Protein Promotes Senescence of 2bs Fibroblasts

Ribonuclease Inhibitor and Angiogenin collaboratively regulate cell-type-specific global translation

Evolutionarily conserved autoregulation of alternative pre-mRNA splicing by ribosomal protein L10a

Proteasomal degradation of Sfp1 contributes to the repression of ribosome biogenesis during starvation and is mediated by the proteasome activator Blm10